Investigational triple-receptor research, clearly presented.
Retatrutide is an investigational once-weekly peptide being evaluated in authorised clinical trials for obesity and related metabolic conditions. It acts as a triple agonist at the GIP, GLP-1 and glucagon receptors and has not been approved for commercial or personal use.
Retatrutide, also known as LY3437943, is an investigational triple-receptor agonist designed to activate the GIP, GLP-1 and glucagon receptor pathways. It is currently being studied in Phase 3 clinical trials to assess its safety and efficacy in adults with obesity, overweight and associated health conditions. Retatrutide has not received UK marketing authorisation, and no commercially approved retatrutide pen is currently available. It must not be presented as an approved weight-loss treatment, supplied for self-administration or used outside an appropriately authorised clinical trial.
Continue to secure checkout
No invented urgency and no hidden payment route—just the information and confirmations needed to make an informed decision.
Read the product description, status, intended context and research-use notice.
Confirm the product, delivery details, research-use declaration and final price.
Complete the current checkout using whichever Stripe card or crypto option is currently configured.
Read the complete product information and research-use statement on this page, then confirm the required declarations during checkout.
The live availability indicator and checkout status show whether an order can currently proceed.
The checkout presents whichever existing methods are currently configured, including Stripe card payment and the available cryptocurrency options.
Yes. Use Svelta-GPT for product-navigation help or continue the conversation in the Svelta Labs Community before ordering.
Well Being
NAD+ 1000mg is a high-dose formulation of nicotinamide adenine dinucleotide, an essential coenzyme naturally present in living cells. It is not a peptide, but a dinucleotide coenzyme involved in cellular energy production, redox reactions and DNA-repair pathways.
Well Being
MOTS-c is a naturally occurring mitochondrial-derived peptide involved in cellular energy regulation and metabolic signalling. Originally identified in 2015, it remains an active area of scientific research for its role in metabolic adaptation and exercise-related pathways.
Weight Loss Pens
Svelta Labs Tirzepatide Pen is a once-weekly, pre-filled prescription treatment intended to support weight management alongside a reduced-calorie diet and increased physical activity. Treatment must be prescribed following an appropriate clinical assessment and used exactly as directed by a qualified healthcare professional.
Review the final declarations and choose from the card or crypto options currently configured in the existing secure checkout.